View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Service Listings   |   Industry News   |   Events
September 04, 2018
learn more
Newsletter Sponsor
  Development of a Lyophilized Biosimilar

Case Study: The patents for a number of parental biologic formulations are destined to expire in the United States between 2016 and 2027. This provides development opportunities for many companies, but also provides significant challenges. The biosimilar must closely match the analytical testing requirements for the biologic developed by the innovator company, as well as many other possible requirements.

more info

» Industry News
 
more news
» Featured Articles
Designing Phase-Appropriate Stability Study Programs for Drug Substances and Drug Products
Stability is a critical quality attribute of pharmaceutical products and is a function of many factors, including the active drug substance itself, the excipients used within the formulation, the ... read more »
HORIZON LINES: A Quarterly Review of NDAs – January-March 2018
This quarterly review on New Drug Applications contains data for applications approved for the first time during the first quarter of 2018, which includes New Molecular Entities (NMEs) and new ... read more »
more articles
 
» Featured Partners
learn more
  Full-Service Aseptic Fill Finish and Lyophilization Services

With the infrastructure and know-how to successfully complete development and commercialization projects from beginning to end, and an extensive track record of overcoming development challenges and protecting valuable assets, LSNE can help you minimize mistakes and maximize opportunities for success. read more »
» Featured Video
learn more
  Watch Video: A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies
Watch Video: A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies read more »
learn more
  Watch Video: Pyramid Laboratories Facility Tour
PYRAMID Laboratories, Inc. is a CDMO, focused on parenteral drug products, that offers comprehensive pipeline of services to pharmaceutical and biotech companies. read more »

more videos
 
» Featured Whitepaper
Considerations for Development of a Lyophilized Biosimilar
The patents for a number of parental biologic formulations are destined to expire in the United States between 2016 and 2027. This provides ... read more »
Process Development for Lyophilized Products
Identifying the failure points for a product is a necessary part of product development, and enables the development scientist to design a ... read more »
more articles
 
| Events
EVENT
  ChemOutsourcing 2018
Long Branch, NJ –  09/17/2018
ChemOutsourcing is the largest USA-based API show attracting annually 700-800 chemists and business development personnel from the pharmaceutical, ...
event details »
EVENT
  DCAT Week ‘19
New York City, NY –  03/18/2019
DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It ...
event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA